Germline Variation Predicts Treatment Response in Multiple Myeloma
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019Profiling the Cell Surface Landscape of Proteasome Inhibitor-Treated and _Resistant Multiple Myeloma to Guide Immunotherapy Targeting, Diagnosis, and Biology
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019Cord Blood Regulatory T Cells Prevent Mutiple Myeloma Progression By Suppressing Inflammation
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)Clinically Relevant Abstract
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019Updated Results from an Ongoing Phase 1 Clinical Study of bb21217 Anti-Bcma CAR T Cell Therapy
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019Novel Prognostic Scoring System for Autologous Hematopoietic Cell Transplantation (AHCT) in Multiple Myeloma (MM)
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnose...
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation
Nina D. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019- Join now to see all